TEVA Trading Analysis - 09/16/2026 11:11 AM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for TEVA include:

• Teva Pharmaceutical Industries Ltd. (TEVA) announced a settlement with the US Department of Justice regarding allegations of misbranding and off-label promotion of certain medications.
• TEVA reported strong quarterly earnings, beating analyst expectations and citing growth in its generics and specialty medicines business.
• The company announced a partnership with a leading research institution to develop new treatments for a range of diseases.

These headlines suggest that TEVA is actively addressing regulatory concerns, delivering strong financial performance, and investing in research and development.

Fundamental Analysis:

Based on the provided fundamentals data:

• Revenue: $14.10B
• Trailing EPS: $0.60
• Trailing P/E: 65.42
• Price-to-Book: 11.77
• Debt-to-Equity: 4.14
• Return on Equity (ROE): 9.14%
• Gross Margin: 64.41%
• Operating Margin: 11.36%
• Profit Margin: 5.03%

TEVA has a high P/E ratio, suggesting potential overvaluation. However, the company's strong revenue growth and expanding profit margins are positive indicators. The high debt-to-equity ratio is a concern, but TEVA's return on equity is respectable.

Current Market Position:

TEVA's current price is $38.77. Recent price action shows:

• 5-day SMA: $38.04
• 20-day SMA: $37.26
• 50-day SMA: $35.12

Intraday momentum is positive, with the stock trading near its recent highs.

Technical Analysis:

Key technical indicators:

• RSI (14): 54.82
• MACD: 0.74 (above signal line)
• Bollinger Bands: Middle band $37.26, Upper band $39.04, Lower band $35.48

TEVA's RSI suggests neutral momentum, while the MACD indicates a bullish trend. The stock is trading near the upper Bollinger Band, which could indicate overbought conditions.

True Sentiment Analysis (Delta 40-60 Options):

Options flow sentiment is strongly bullish:

• Call dollar volume: $3050797
• Put dollar volume: $11637
• Call %: 99.6%

The overwhelming dominance of call buying suggests that traders are positioning for further upside in TEVA.

Key Price Levels:

Support levels:

• $35.12 (50-day SMA)
• $35.48 (lower Bollinger Band)

Resistance levels:

• $39.04 (upper Bollinger Band)
• $39.49 (30-day high)

25-Day Price Forecast:

Based on current trends and indicators, TEVA is projected for $39.50 to $41.20 in 25 days.

This range is based on:

• Continued bullish momentum from the MACD and options flow
• Resistance levels near $39.49 and $40.00
• Recent volatility (ATR: 1.20)

Defined Risk Strategy Recommendations:

Based on the forecast, consider:

• Bull Call Spread: Buy $38.00 call, sell $40.00 call (expiration: 2026-10-16)
• Risk/Reward: 2.5:1
• Iron Condor: Sell $39.00 call, buy $41.00 call, sell $35.00 put, buy $33.00 put (expiration: 2026-10-16)

Risk Factors:

Potential risks:

• Technical weakness: break below 50-day SMA
• Sentiment divergence: decrease in call buying
• Volatility increase: ATR expansion

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: High

Trade idea: TEVA has bullish momentum and sentiment, targeting $39.50-$41.20.